Table 2.
Susceptibility of Pseudomonas aeruginosa Isolates According to Antibiotic Use at Time of Bacteremia
| Antibiotic | Antibiotic | P Value | |
|---|---|---|---|
| FQ (n = 26) | Non-FQ or None (n = 29) | ||
| Susceptible isolates, n (%) | Susceptible isolates, n (%) | ||
| Ciprofloxacin | 0 | 21 (72.4) | <.0001 |
| Meropenem | 4 (15.4) | 21 (72.4) | <.0001 |
| Cefepime | 21 (80.8) | 26 (89.6) | .4 |
| Ceftazidime | 19 (73.1) | 25 (86.2) | .3 |
| Gentamicin | 21 (80.8) | 28 (96.5) | .1 |
| P/T | 19 (73.1) | 25 (86.2) | .3 |
| Tobramycin | 25 (96.1) | 29 (100) | .5 |
Abbreviations: FQ, fluoroquinolone; P/T, piperacillin-tazobactam.